CDK4: A Key Player in the Cell Cycle, Development, and Cancer

Area of Science:

• Cell Biology
• Molecular Biology
• Oncology

Background:

• The cell cycle is a fundamental biological process regulated by cyclins and cyclin-dependent kinases (CDKs).
• CDK4, partnered with D-type cyclins, is essential for the G1 phase of the cell cycle, preparing cells for DNA synthesis.
• While other CDKs can compensate for CDK4 loss in vitro, it remains vital for mammalian development and cancer progression.

Purpose of the Study:

• To review the critical role of CDK4 in cell cycle regulation.
• To discuss the involvement of CDK4 in normal mammalian development.
• To explore the function of CDK4 in tumorigenesis and the therapeutic potential of CDK4 inhibitors.

Main Methods:

• Literature review of studies on CDK4 function.
• Analysis of data from CDK4-null mutant mice.
• Examination of research on small molecule CDK4 inhibitors.

Main Results:

• CDK4 plays a significant role in mammalian development despite compensatory mechanisms.
• Dysregulation of CDK4 is implicated in various forms of cancer.
• Small molecule inhibitors targeting CDK4 have shown promise in preclinical studies.

Conclusions:

• CDK4 is a key regulator of the cell cycle and a critical factor in development and cancer.
• Targeting CDK4 with small molecule inhibitors represents a viable therapeutic approach for treating CDK4-driven diseases.